New solid forms of n-[(1s,2e)-1-cyclopropyl-3-(methanesulfonyl)prop-2-en-1-yl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide
CO20260011085A2Pending Publication Date: 2026-08-20VIVIDION THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260011085
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-09
- Filing Date
- 2026-07-31
- Publication Date
- 2026-08-20
Abstract
The present invention provides solid forms of N-[(1S,2E)-1-cyclopropyl-3-(methanesulfonyl)prop-2-en-1-yl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide and its solvates, as well as their therapeutic uses and a pharmaceutical composition comprising the same.
Need to check novelty before this filing date? Find Prior Art